Insider Transactions in Q1 2025 at Allstate Corp (ALL)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2025
|
Thomas J Wilson Chairman, President & CEO |
SELL
Open market or private sale
|
Indirect |
31,503
-9.13%
|
$5,922,564
$188.29 P/Share
|
|
Feb 21
2025
|
Zulfikar Jeevanjee |
SELL
Payment of exercise price or tax liability
|
Direct |
242
-3.1%
|
$44,770
$185.66 P/Share
|
|
Feb 21
2025
|
Zulfikar Jeevanjee |
BUY
Exercise of conversion of derivative security
|
Direct |
754
+8.8%
|
-
|
|
Feb 21
2025
|
Mario Rizzo |
SELL
Payment of exercise price or tax liability
|
Direct |
769
-1.11%
|
$142,265
$185.66 P/Share
|
|
Feb 21
2025
|
Mario Rizzo |
BUY
Exercise of conversion of derivative security
|
Direct |
1,832
+2.57%
|
-
|
|
Feb 21
2025
|
Mark Q Prindiville |
SELL
Payment of exercise price or tax liability
|
Direct |
154
-0.69%
|
$28,490
$185.66 P/Share
|
|
Feb 21
2025
|
Mark Q Prindiville |
BUY
Exercise of conversion of derivative security
|
Direct |
570
+2.48%
|
-
|
|
Feb 21
2025
|
Jesse E Merten EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
668
-3.08%
|
$123,580
$185.66 P/Share
|
|
Feb 21
2025
|
Jesse E Merten EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,507
+6.51%
|
-
|
|
Feb 21
2025
|
John E Dugenske |
SELL
Payment of exercise price or tax liability
|
Direct |
690
-2.05%
|
$127,650
$185.66 P/Share
|
|
Feb 21
2025
|
John E Dugenske |
BUY
Exercise of conversion of derivative security
|
Direct |
1,557
+4.42%
|
-
|
|
Feb 21
2025
|
Suren Gupta |
SELL
Payment of exercise price or tax liability
|
Direct |
396
-0.42%
|
$73,260
$185.66 P/Share
|
|
Feb 21
2025
|
Suren Gupta |
BUY
Exercise of conversion of derivative security
|
Direct |
942
+0.99%
|
-
|
|
Feb 21
2025
|
Elizabeth Brady |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-1.25%
|
$51,430
$185.66 P/Share
|
|
Feb 21
2025
|
Elizabeth Brady |
BUY
Exercise of conversion of derivative security
|
Direct |
662
+2.88%
|
-
|
|
Feb 21
2025
|
Christine M. De Biase EVP, CLO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
304
-7.55%
|
$56,240
$185.66 P/Share
|
|
Feb 21
2025
|
Christine M. De Biase EVP, CLO and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
904
+18.33%
|
-
|
|
Feb 17
2025
|
Suren Gupta |
SELL
Payment of exercise price or tax liability
|
Direct |
1,586
-1.67%
|
$296,582
$187.63 P/Share
|
|
Feb 17
2025
|
Suren Gupta |
BUY
Grant, award, or other acquisition
|
Direct |
5,326
+5.31%
|
-
|
|
Feb 17
2025
|
Jesse E Merten EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,618
-7.43%
|
$302,566
$187.63 P/Share
|
|
Feb 17
2025
|
Jesse E Merten EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,652
+14.37%
|
-
|
|
Feb 14
2025
|
Elizabeth Brady |
SELL
Payment of exercise price or tax liability
|
Direct |
1,063
-4.69%
|
$198,781
$187.63 P/Share
|
|
Feb 14
2025
|
Elizabeth Brady |
BUY
Grant, award, or other acquisition
|
Direct |
3,526
+13.45%
|
-
|
|
Feb 14
2025
|
Thomas J Wilson Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,674
-5.64%
|
$2,557,038
$187.63 P/Share
|
|
Feb 14
2025
|
Thomas J Wilson Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
32,663
+11.87%
|
-
|
|
Feb 14
2025
|
Mario Rizzo |
SELL
Payment of exercise price or tax liability
|
Direct |
2,256
-3.23%
|
$421,872
$187.63 P/Share
|
|
Feb 14
2025
|
Mario Rizzo |
BUY
Grant, award, or other acquisition
|
Direct |
6,847
+8.92%
|
-
|
|
Feb 14
2025
|
Mark Q Prindiville |
SELL
Payment of exercise price or tax liability
|
Direct |
923
-4.05%
|
$172,601
$187.63 P/Share
|
|
Feb 14
2025
|
Mark Q Prindiville |
BUY
Grant, award, or other acquisition
|
Direct |
3,043
+11.78%
|
-
|
|
Feb 14
2025
|
John E Dugenske |
SELL
Payment of exercise price or tax liability
|
Direct |
2,815
-8.06%
|
$526,405
$187.63 P/Share
|
|
Feb 14
2025
|
John E Dugenske |
BUY
Grant, award, or other acquisition
|
Direct |
8,110
+18.84%
|
-
|
|
Feb 10
2025
|
Jesse E Merten EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40,102
-23.61%
|
$7,499,074
$187.59 P/Share
|
|
Feb 10
2025
|
Jesse E Merten EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,102
+17.22%
|
$4,531,526
$113.2 P/Share
|
|
Feb 03
2025
|
Christine M. De Biase EVP, CLO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
876
-21.9%
|
$167,316
$191.98 P/Share
|
|
Feb 03
2025
|
Christine M. De Biase EVP, CLO and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,538
+38.82%
|
-
|
|
Jan 21
2025
|
Thomas J Wilson Chairman, President & CEO |
SELL
Open market or private sale
|
Indirect |
31,503
-8.55%
|
$6,048,576
$192.0 P/Share
|
|
Jan 01
2025
|
Margaret M Keane Director |
BUY
Grant, award, or other acquisition
|
Direct |
175
+1.2%
|
$33,600
$192.79 P/Share
|
|
Jan 01
2025
|
Perry M Traquina Director |
BUY
Grant, award, or other acquisition
|
Direct |
213
+4.3%
|
$40,896
$192.79 P/Share
|
|
Jan 01
2025
|
Donald Eugene Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
220
+3.91%
|
$42,240
$192.79 P/Share
|